Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones.
Mol Ther Methods Clin Dev. 2021 Oct 16;23:424-433. doi: 10.1016/j.omtm.2021.10.003. eCollection 2021 Dec 10.
Mol Ther Methods Clin Dev. 2021.
PMID: 34786435
Free PMC article.
A Distinct Feature of T Cell Subpopulations in a Patient with CHARGE Syndrome and Omenn Syndrome.
Uchiyama T, Kawakami S, Masuda H, Yoshida K, Niizeki H, Mochizuki E, Edasawa K, Ishiguro A, Onodera M.
Uchiyama T, et al. Among authors: edasawa k.
J Clin Immunol. 2021 Jan;41(1):233-237. doi: 10.1007/s10875-020-00875-7. Epub 2020 Oct 6.
J Clin Immunol. 2021.
PMID: 33025375
No abstract available.
Item in Clipboard
Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD.
Uchiyama T, Kawai T, Nakabayashi K, Nakazawa Y, Goto F, Okamura K, Nishimura T, Kato K, Watanabe N, Miura A, Yasuda T, Ando Y, Minegishi T, Edasawa K, Shimura M, Akiba Y, Sato-Otsubo A, Mizukami T, Kato M, Akashi K, Nunoi H, Onodera M.
Uchiyama T, et al. Among authors: edasawa k.
Mol Ther. 2023 Dec 6;31(12):3424-3440. doi: 10.1016/j.ymthe.2023.09.004. Epub 2023 Sep 13.
Mol Ther. 2023.
PMID: 37705244
Item in Clipboard
Cite
Cite